期刊文献+

CT diagnosis of recurrence after pancreatic cancer:Is there a pattern? 被引量:7

CT diagnosis of recurrence after pancreatic cancer:Is there a pattern?
暂未订购
导出
摘要 AIM:To investigate predilection sites of recurrence of pancreatic cancer by computed tomography(CT)in follow-up after surgery. METHODS:Seventy seven patients with recurrence after pancreatic cancer surgery were retrospectively identified.The operative technique,R-status,T-stage and development of tumor markers were evaluated. Two radiologists analyzed CT scans with consensus readings.Location of local recurrence,lymph node recurrence and organ metastases were noted.Surgery and progression of findings on follow-up CT were con-sidered as reference standard. RESULTS:The mean follow-up interval was 3.9± 1.8 mo,with a mean relapse-free interval of 12.9± 10.4 mo.The predominant site of recurrence was local (65%),followed by lymph node(17%),liver metastasis (11%)and peritoneal carcinosis(7%).Local recurrence emerged at the superior mesenteric artery(n=28),the hepatic artery(n=8),in an area defined by the surrounding vessels:celiac trunk,portal vein,inferior vena cava(n=22),and in a space limited by the mesenteric artery,portal vein and inferior vena cava(n=17). Lymph node recurrence occurred in the mesenteric root and left lateral to the aorta.Recurrence was confirmed by surgery(n=22)and follow-up CT(n=55).Tumor markers[carbohydrate antigen 19-9(CA19-9),carcinoembryonic antigen(CEA)]increased in accordance with signs of recurrence in most cases(86%CA19-9;79.2% CEA). CONCLUSION:Specific changes of local and lymph node recurrence can be found in the course of the cardinal peripancreatic vessels.The superior mesenteric artery is the leading structure for recurrence. AIM:To investigate predilection sites of recurrence of pancreatic cancer by computed tomography(CT)in follow-up after surgery. METHODS:Seventy seven patients with recurrence after pancreatic cancer surgery were retrospectively identified.The operative technique,R-status,T-stage and development of tumor markers were evaluated. Two radiologists analyzed CT scans with consensus readings.Location of local recurrence,lymph node recurrence and organ metastases were noted.Surgery and progression of findings on follow-up CT were con-sidered as reference standard. RESULTS:The mean follow-up interval was 3.9± 1.8 mo,with a mean relapse-free interval of 12.9± 10.4 mo.The predominant site of recurrence was local (65%),followed by lymph node(17%),liver metastasis (11%)and peritoneal carcinosis(7%).Local recurrence emerged at the superior mesenteric artery(n=28),the hepatic artery(n=8),in an area defined by the surrounding vessels:celiac trunk,portal vein,inferior vena cava(n=22),and in a space limited by the mesenteric artery,portal vein and inferior vena cava(n=17). Lymph node recurrence occurred in the mesenteric root and left lateral to the aorta.Recurrence was confirmed by surgery(n=22)and follow-up CT(n=55).Tumor markers[carbohydrate antigen 19-9(CA19-9),carcinoembryonic antigen(CEA)]increased in accordance with signs of recurrence in most cases(86%CA19-9;79.2% CEA). CONCLUSION:Specific changes of local and lymph node recurrence can be found in the course of the cardinal peripancreatic vessels.The superior mesenteric artery is the leading structure for recurrence.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2011年第9期1126-1134,共9页 世界胃肠病学杂志(英文版)
关键词 Pancreatic cancer RECURRENCE Computed tomography FOLLOW-UP Tumor marker CT扫描 胰腺癌 复发 计算机断层扫描 肿瘤标志物 诊断 癌胚抗原 肝动脉
  • 相关文献

参考文献33

  • 1Carpelan-Holmstrom M, Nordling S, Pukkala E, Sankila R, Luttges J, Kloppel G, Haglund C. Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry. Gut 2005; 54:385-387.
  • 2Barugola G, Falconi M, Bettini R, Boninsegna L, Casarotto A, Salvia R, Bassi C, Pederzoli P. The determinant factors of recurrence following resection for ductal pancreatic cancer. JOP 2007; 8:132-140.
  • 3Rocha-Lima CM. New directions in the management of ad- vanced pancreatic cancer: a review. Anticancer Drugs 2008; 19:435-446.
  • 4Neoptolemos JP. Clinical evidence does not support the use of adjuvant radiotherapy in pancreatic cancer. Nat Clin Pract Oncol 2008; 5: 431.
  • 5Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H, Beget H, Fernandez-Cruz L, Dervenis C, Lacaine F, Falconi M, Pederzoli P, Pap A, Spooner D, Kerr DJ, Btichler MW. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 2004; 350:1200-1210.
  • 6Valentini V, Morganti AG, Macchia G, Mantini G, Mat- tiucci GC, Brizi MG, Alfieri S, Bossola M, Pacelli F, Sofo L, Doglietto G, Cellini N. Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis. Int J Ra- diat Oncol Biol Phys 2008; 70:1094-1099.
  • 7Kleeff J, Michalski C, Friess H, Buchler MW. Pancreatic can- cer: from bench to 5-year survival. Pancreas 2006; 33:111-118.
  • 8Saif MW. Pancreatic cancer: highlights from the 42nd an- nual meeting of the American Society of Clinical Oncology, 2006. JOP 2006; 7:337-348.
  • 9Bluemke DA, Abrams RA, Yeo CJ, Cameron JL, Fishman EK. Recurrent pancreatic adenocarcinoma: spiral CT evalu- ation following the Whipple procedure. Radiographics 1997; 17:303-313.
  • 10Wilkowski R, Thoma M, Bruns C, Duhmke E, Heinemann V. Combined chemoradiotherapy for isolated local recurrence after primary resection of pancreatic cancer. JOP 2006; 7:34-40.

同被引文献23

引证文献7

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部